Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1203 (LINC01203) is a long non-coding RNA (lncRNA) belonging to the subclass of long intergenic non-coding RNAs (lincRNAs).[5] LincRNAs are defined as RNA transcripts longer than 200 nucleotides that do not overlap with protein-coding genes and are transcribed independently.[1][3] These RNAs usually act within the nucleus and are involved in chromatin remodeling, regulation of transcription, stabilization of RNA, and sometimes act as enhancers or in fine-tuning the expression of neighboring genes.[1][3] While a small number of lincRNAs have been functionally characterized with established roles in gene regulation and disease (most notably cancer), the specific biological function and potential clinical significance of LINC01203 remain unclear, and there are currently no known drugs or therapeutics that target this RNA directly.[1][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1203 (LINC01203).